Brief: ImmuCell Corporation FY EPS USD -0.12
04/03/2026 21:05
Mar 04 (Reuters) - ImmuCell Corporation FY net income USD -1.04 million. FY pretax profit USD -1.029 million FY operating expenses USD 9.796 million
Recent news on ImmuCell
See all newsBrief: Immucell Announces A 46% Increase In Product Sales In Quarter Three Of 2026, Based On Preliminary, Unaudited Sales Results
ImmuCell Q2 revenue rises on higher distributor volume, price realization
Brief: ImmuCell Corporation Q2 EPS USD 0.2
ImmuCell Q2 product sales rise 11.5% on strong US demand
ImmuCell Q1 sales, profit rise on seasonal demand; to moderate mid-year